Recurrent Vulvovaginal Candidiasis: Could It Be Related to Cell-Mediated Immunity Defect in Response to Candida Antigen?
Open Access
- 1 October 2017
- journal article
- Vol. 11 (3) , 134-141
Abstract
Recurrent vulvovaginal candidiasis (RVVC) is a common cause of morbidity affecting millions of women worldwide. Patients with RVVC are thought to have an underlying immunologic defect. This study has been established to evaluate cell-mediated immunity defect in response to candida antigen in RVVC cases.Our cross-sectional study was performed in 3 groups of RVVC patients (cases), healthy individuals (control I) and known cases of chronic mucocutaneous candidiasis (CMC) (control II). Patients who met the inclusion criteria of RVVC were selected consecutively and were allocated in the case group. Peripheral blood mononuclear cells were isolated and labeled with CFSE and proliferation rate was measured in exposure to candida antigen via flow cytometry.T lymphocyte proliferation in response to candida was significantly lower in RVVC cases (n=24) and CMC patients (n=7) compared to healthy individuals (n=20, 0.05). Family history of primary immunodeficiency diseases (PID) differed significantly among groups (P=0.01), RVVC patients has family history of PID more than control I (29.2 vs. 0%, P=0.008) but not statistically different from CMC patients (29.2 vs. 42.9%, P>0.05). Prevalence of atopy was greater in RVVC cases compared to healthy individuals (41.3 vs. 15%, P=0.054). Lymphoproliferative activity and vaginal symptoms were significantly different among RVVC cases with and without allergy (P=0.01, P=0.02).Our findings revealed that T cells do not actively proliferate in response to Candida antigen in some RVVC cases. So it is concluded that patients with cell-mediated immunity defect are more susceptible to recurrent fungal infections of vulva and vagina. Nonetheless, some other cases of RVVC showed normal function of T cells. Further evaluations showed that these patients suffer from atopy. It is hypothesized that higher frequency of VVC in patients with history of atopy might be due to allergic response in mucocutaneous membranes rather than a functional impairment in immune system components.Keywords
This publication has 47 references indexed in Scilit:
- Autosomal-Dominant Chronic Mucocutaneous Candidiasis with STAT1-Mutation can be Complicated with Chronic Active Hepatitis and HypothyroidismJournal of Clinical Immunology, 2012
- Vaginal yeast colonisation, prevalence of vaginitis, and associated local immunity in adolescentsSexually Transmitted Infections, 2004
- Candida‐Specific Systemic Cell‐Mediated Immune Reactivities in Human Immunodeficiency Virus–Positive Persons with Mucosal CandidiasisThe Journal of Infectious Diseases, 2001
- The study of cell-mediated immune response in recurrent vulvovaginal candidiasisFEMS Immunology & Medical Microbiology, 2000
- Diagnostic Criteria for Primary ImmunodeficienciesClinical Immunology, 1999
- Is Vulvovaginal Candidiasis an AIDS-Related Illness?Clinical Infectious Diseases, 1996
- The epidemiology of vulvovaginal candidiasis among university students.American Journal of Public Health, 1995
- Oral mycoses in HIV infectionOral Surgery, Oral Medicine, Oral Pathology, 1992
- Recurrent Vulvovaginal CandidiasisNew England Journal of Medicine, 1986
- Allergy in chronic monilial vaginitis.1971